A French think-tank has published a report examining the potentially "perverse effects" of adopting UK-style health care financing policies in France under the "loi Bachelot," a reform package currently under discussion by the National Assembly.
A particular concern of the Institut economique Molinari's paper is the growing control of physicians by government authorities, including trying to force newly-qualified doctors to move to underprovided areas. Guillaume Vuillemey, the report's author, notes that this has the unintended consequence of making a career in medicine less attractive, or inciting health care professionals to emigrate, worsening the shortage in parts of France.
The report examines the role of the National Institute for Health and Clinical Excellence (NICE), the body that determines which medicines will be covered by the National Health Service across the UK apart from Scotland. Mr Vuillemey concludes that the implementation of a similar system in France would involve restricting access to new drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze